Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 384

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 384
---
 Total finance expense                 |     |         41 |     |         53 |     |         44 |

The gain on the equity
settled derivative financial liability in 2023, 2022 and 2021 arose as a result of the movement in share price (note 18).

| F-45 |

| 7 | Taxation |

| Schedule of components of income tax expense |     |            |   |     |            |     |            |
|                                              |     | 2023 £’000 |   |     | 2022 £’000 |     | 2021 £’000 |
| Current tax credit                           |     |            |   |     |            |     |            |
| Current tax credited to the income statement |     |        407 |   |     |        825 |     |        646 |
| Adjustment in respect of prior year          |     |         (1 | ) |     |          7 |     |          – |
| Current tax credit                           |     |        406 |   |     |        832 |     |        646 |
| Deferred tax credit                          |     |            |   |     |            |     |            |
| Reversal of temporary differences            |     |          – |   |     |          – |     |          – |
| Total tax credit                             |     |        406 |   |     |        832 |     |        646 |

The reasons for the
difference between the actual tax charge for the year and the standard rate of corporation tax in the United Kingdom applied to losses
for the year are as follows:

| Schedule of difference between actual tax charge and the standard rate of corporation tax                                              |     |            |   |     |            |   |     |            |   |
|                                                                                                                                        |     | 2023 £’000 |   |     | 2022 £’000 |   |     | 2021 £’000 |   |
| Loss before tax                                                                                                                        |     |     (7,485 | ) |     |     (8,488 | ) |     |     (6,106 | ) |
| Expected tax credit based on the standard rate of United Kingdom corporation tax at the domestic rate of 23.52% (2021: 19%; 2020: 19%) |     |     (1,764 | ) |     |     (1,613 | ) |     |     (1